Comprehensive medication management services
Product and provider description
Target populations
Target condition & treatment
Adherence monitoring
Adherence support
Development and evaluation
Product and provider description
Brand name:
Farmakoterapijsko savjetovalište
Farmakoterapijsko savjetovalište
Full name:
Comprehensive medication management services
Comprehensive medication management services
Brief description:
CMM services is an evidence-based and patient-centred clinical practice, provided by pharmacists with an aim of preventing, identifying and resolving drug therapy problems to optimize patients’ medication experience and clinical outcomes. Through a rational and standardized process, the pharmacist reviews the medications in use by the patient and identifies possible problems associated with their appropriateness, effectiveness, safety and adherence. In addition to the comprehensive assessment of patient’s drug-related needs, CMM includes the development of an individualized care plan to achieve the desired goals of therapy with the patient, as well as appropriate follow-up to evaluate actual patient outcomes that result from the implementation of the care plan.
CMM services is an evidence-based and patient-centred clinical practice, provided by pharmacists with an aim of preventing, identifying and resolving drug therapy problems to optimize patients’ medication experience and clinical outcomes. Through a rational and standardized process, the pharmacist reviews the medications in use by the patient and identifies possible problems associated with their appropriateness, effectiveness, safety and adherence. In addition to the comprehensive assessment of patient’s drug-related needs, CMM includes the development of an individualized care plan to achieve the desired goals of therapy with the patient, as well as appropriate follow-up to evaluate actual patient outcomes that result from the implementation of the care plan.
Technology Readiness Level:
TRL 9: Full commercial application
TRL 9: Full commercial application
Date first available:
2018-01-08
2018-01-08
Date latest update:
2022-11-07
2022-11-07
Current version identifier:
Not applicable
Not applicable
Types of components:
Software, Service, Non-electronic equipment or material
Software, Service, Non-electronic equipment or material
Is the technology designed to be used as stand-alone or/and as component of a larger solution:
As a stand-alone solution
As a stand-alone solution
Languages:
Croatian
Croatian
Countries:
Croatia
Croatia
Do any terms and conditions apply?
No
No
Is the technology free of charge or a fee is required for its use?
Free
Free
Provider name:
Health care Centre Zagreb Center; Faculty of Pharmacy and Biochemistry University of Zagreb
Health care Centre Zagreb Center; Faculty of Pharmacy and Biochemistry University of Zagreb
Provider type:
Public or state-owned organisation
Public or state-owned organisation
Provider domain of activity:
Technology, Pharmaceutical, Healthcare, Research and/or education
Technology, Pharmaceutical, Healthcare, Research and/or education
Please contact the provider at:
farmasavjetovaliste@dzz-centar.hr or fts@dzz-centar.hr; +38599583 8382 or +38591 489 7038
farmasavjetovaliste@dzz-centar.hr or fts@dzz-centar.hr; +38599583 8382 or +38591 489 7038
Target populations
Is the MATech intended to be used for self-management?
No
No
Who interacts with the MATech for self-management?
No information available
No information available
How many interact:
multiple persons/users (e.g. communication between different users possible via the MATech)
multiple persons/users (e.g. communication between different users possible via the MATech)
Patient age group(s) the MATech is suitable for:
Older adults – older than 65 years, Adults – 31 – 65 years old, Young adults – 18 – 30 years old
Older adults – older than 65 years, Adults – 31 – 65 years old, Young adults – 18 – 30 years old
Level of functioning in memory functions the MATech is suitable for:
mild impairment
mild impairment
Level of functioning in perception functions the MATech is suitable for:
no impairment
no impairment
Level of functioning in visual functions the MATech is suitable for:
mild impairment
mild impairment
Level of functioning in auditive functions the MATech is suitable for:
mild impairment
mild impairment
Level of functioning in movement & mobility the MATech is suitable for:
severe impairment
severe impairment
Is the MATech suitable for patients with low literacy (ability to read and write)?
Not known
Not known
Is the MATech suitable for patients with low health literacy (capacity to obtain, process and understand basic health information and services)?
Not known
Not known
Is the MATech suitable for patients with comorbidity?
Yes
Yes
Is the MATech suitable for patients with limited experience with technologies?
Yes
Yes
Is the MATech intended to be used for within an adherence support service?
Yes
Yes
Is the MATech intended to be used by health or social care providers?
Yes
Yes
Is the MATech intended to be used by administrators or health system managers?
No
No
Target condition & treatment
Target health condition domains for which the MATech is designed:
Blood, Cancer and neoplasms, Cardiovascular, Congenital disorder, Ear, Eye, Infection, Inflammatory and immune system, Injuries and accidents, Mental health, Metabolic and endocrine, Musculoskeletal, Neurological, Oral and gastrointestinal, Renal and urogenital, Reproductive health and childbirth, Respiratory, Skin, Stroke, Generic health relevance
Blood, Cancer and neoplasms, Cardiovascular, Congenital disorder, Ear, Eye, Infection, Inflammatory and immune system, Injuries and accidents, Mental health, Metabolic and endocrine, Musculoskeletal, Neurological, Oral and gastrointestinal, Renal and urogenital, Reproductive health and childbirth, Respiratory, Skin, Stroke, Generic health relevance
The MATech is suitable for medication prescribed:
Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events, e.g. exacerbations, organ rejections etc.), Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)
Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events, e.g. exacerbations, organ rejections etc.), Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)
The MATech is suitable for (treatment duration):
Short-term treatment(s), Long-term treatment(s)
Short-term treatment(s), Long-term treatment(s)
The MATech is suitable for (administration form):
Oral forms, Inhalation, Injection (subcutaneous), Infusion (parenteral), Transdermal forms (patches), Topical forms
Oral forms, Inhalation, Injection (subcutaneous), Infusion (parenteral), Transdermal forms (patches), Topical forms
The MATech is suitable for (single/polypharmacy):
Single drug treatments, Polypharmacy (combination therapies)
Single drug treatments, Polypharmacy (combination therapies)
The MATech is suitable for (dosage instructions):
Once-daily doses, Multiple doses in a fixed posology (eg. twice-daily), Once-per-week doses, Multiple doses on certain days per week, The technology is capable to deal with dose adjustments
Once-daily doses, Multiple doses in a fixed posology (eg. twice-daily), Once-per-week doses, Multiple doses on certain days per week, The technology is capable to deal with dose adjustments
The MATech is designed to be used for adherence monitoring or intervention:
Monitor/measure medication adherence, Intervene to support medication adherence
Monitor/measure medication adherence, Intervene to support medication adherence
Brief description:
As a part of the CMM services (being a MATech) we tailoring an individual care plan and addressing patient’s (non)adherence in various ways (explaining the importance of taking their meds regularly, explaining the consequences of irregular drug intake etc.). At each follow-up visit we measure their adherence/non-adherence and that is how we monitor patients’ adherence.
As a part of the CMM services (being a MATech) we tailoring an individual care plan and addressing patient’s (non)adherence in various ways (explaining the importance of taking their meds regularly, explaining the consequences of irregular drug intake etc.). At each follow-up visit we measure their adherence/non-adherence and that is how we monitor patients’ adherence.
The MATech is designed to be used in (adherence phases):
Initiation (when the person starts to take the medication prescribed), Implementation (during the period when the person takes the medication prescribed), Discontinuation (when the person stops taking the medication prescribed)
Initiation (when the person starts to take the medication prescribed), Implementation (during the period when the person takes the medication prescribed), Discontinuation (when the person stops taking the medication prescribed)
Adherence monitoring
Methods used by the MATech to measure adherence:
Self-report, Electronic monitoring, Electronic healthcare database, Laboratory method
Self-report, Electronic monitoring, Electronic healthcare database, Laboratory method
Behavioral aspects targeted by the MATech measurement component:
outcomes
outcomes
Behaviors targeted by the MATech measurement component:
medication adherence, alcohol intake, diet, physical activity or sedentarity, tobacco use, symptom monitoring and management
medication adherence, alcohol intake, diet, physical activity or sedentarity, tobacco use, symptom monitoring and management
Outcomes targeted by the MATech measurement component:
clinical (e.g. morbidity, mortality), humanistic (e.g. health-related quality of life, satisfaction), economic (indirect, direct, intangible costs)
clinical (e.g. morbidity, mortality), humanistic (e.g. health-related quality of life, satisfaction), economic (indirect, direct, intangible costs)
Adherence support
Modes of delivering adherence support used in the technology:
Printed material, Human interaction, Electronic
Printed material, Human interaction, Electronic
Printed material formats used:
Brochure, Printed media (e.g. via poster; newspaper or leaflet)
Brochure, Printed media (e.g. via poster; newspaper or leaflet)
Human interaction formats used:
Face-to-face consultations
Face-to-face consultations
Electronic formats used:
Use of a smartphone or tablet
Use of a smartphone or tablet
Smartphone/tablet formats used:
interactive messaging or chat SMS (short text message), audio call, video call, email
interactive messaging or chat SMS (short text message), audio call, video call, email
App features included:
No information available
No information available
Wearable device formats used:
No information available
No information available
Digital media formats used:
website (e.g. patient association, professional society)
website (e.g. patient association, professional society)
Behaviour change content of the intervention (e.g. what adherence barriers and facilitators are targeted, what behaviour change techniques it includes):
Through a rational and standardized process, the pharmacist reviews the medications in use by the patient and identifies possible problems associated with their appropriateness, effectiveness, safety and adherence. In addition to the comprehensive assessment of patient’s drug-related needs, CMM includes the development of an individualized care plan to achieve the desired goals of therapy with the patient, as well as appropriate follow-up to evaluate actual patient outcomes that result from the implementation of the care plan.
Through a rational and standardized process, the pharmacist reviews the medications in use by the patient and identifies possible problems associated with their appropriateness, effectiveness, safety and adherence. In addition to the comprehensive assessment of patient’s drug-related needs, CMM includes the development of an individualized care plan to achieve the desired goals of therapy with the patient, as well as appropriate follow-up to evaluate actual patient outcomes that result from the implementation of the care plan.
Types of intervention providers involved (i.e. persons using the technology to support patients manage adherence):
Pharmacist (Community pharmacist, Hospital pharmacist)
Pharmacist (Community pharmacist, Hospital pharmacist)
Types of intervention setting (i.e. where the technology is designed to be used for supporting adherence):
Household residence, Care home facility, Hospice facility, Community healthcare facility
Household residence, Care home facility, Hospice facility, Community healthcare facility
Telehealth environments applicable:
Telepharmacy
Telepharmacy
Development and evaluation
Brief description of how the technology has been developed and evaluated (e.g. transparency, theory and evidence base, context compatibility, co-creation, scientific evaluation, etc.):
https://pubmed.ncbi.nlm.nih.gov/35270472/ https://pubmed.ncbi.nlm.nih.gov/35455900/ https://pubmed.ncbi.nlm.nih.gov/36136835/ https://pubmed.ncbi.nlm.nih.gov/31639091/ https://pubmed.ncbi.nlm.nih.gov/32493090/
https://pubmed.ncbi.nlm.nih.gov/35270472/ https://pubmed.ncbi.nlm.nih.gov/35455900/ https://pubmed.ncbi.nlm.nih.gov/36136835/ https://pubmed.ncbi.nlm.nih.gov/31639091/ https://pubmed.ncbi.nlm.nih.gov/32493090/
Matech Disclaimer
ENABLE – COST Action CA19132 (ENABLE) maintains this website to enhance public access to our online repository where interested parties would be able to search for medication adherence technologies and learn about them for their research or practice.
Our goal is to keep this information timely and accurate. If errors are brought to our attention, we will try to correct them. However, ENABLE accepts no responsibility or liability whatsoever with regard to the information on this site.